Application of an indocyanine green surgical fluorescence imaging system in sentinel lymph node biopsy of acral malignant melanoma
- PMID: 34734008
- PMCID: PMC8506787
- DOI: 10.21037/atm-21-4366
Application of an indocyanine green surgical fluorescence imaging system in sentinel lymph node biopsy of acral malignant melanoma
Abstract
Background: Regional lymph node status is an independent influencing factor for the prognosis of acral malignant melanoma, and the accuracy of sentinel lymph node biopsy (SLNB) is directly related to the judgment of regional lymph node status. This study aimed to explore the application value of indocyanine green (ICG) surgical fluorescence imaging system in the SLNB of acral malignant melanoma.
Methods: A total of 34 patients with acral malignant melanoma were admitted to the Department of Burn and Plastic Surgery in Jiangsu Provincial People's Hospital from January 2020 to March 2020. Among these patients, 22 required SLNB. ICG and methylene blue (MB) were combined to intraoperatively trace the sentinel lymph nodes (SLNs). The total number of SLNs detected during the operation was counted. We compared the number, detection rate, as well as the detection rate and false negative rate of positive SLNs of SLNs detected by ICG, MB, and ICG combined with MB.
Results: A total of 56 SLNs were detected in the 22 patients, among which 55 were detected by ICG (98%), 41 were detected by MB (71%), and 56 (100%) were detected by ICG combined with MB, and the average number of SLNs were 2.5, 1.64, and 2.55, respectively. A total of nine SLNs were detected, of which nine were detected by ICG (100%), seven by MB (78%), and nine by ICG combined with MB (100%). Patients with negative SLNs had no recurrence at the 6-month follow-up.
Conclusions: Compared with MB, the ICG fluorescent imaging system can improve the detection rate of SLNs in patients with acral malignant melanoma. Also, ICG combined with MB was superior to ICG alone.
Keywords: Acral malignant melanoma; indocyanine green (ICG); methylene blue (MB); sentinel lymph node biopsy (SLNB).
2021 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/atm-21-4366). Dr. HC is an employee of the Nanjing Nuoyuan Medical Devices Co., Ltd., and provided the equipment of the ICG Surgical Fluorescent Imaging System. But the author promises that the paper was not affected during the writing process. The other authors have no conflicts of interest to declare.
Figures


Similar articles
-
Assessing the benefit of using indocyanine green in addition to methylene blue for breast cancer sentinel lymph node biopsy.Medicine (Baltimore). 2025 May 16;104(20):e42500. doi: 10.1097/MD.0000000000042500. Medicine (Baltimore). 2025. PMID: 40388739 Free PMC article.
-
Evaluation of indocyanine green combined with methylene blue staining in sentinel lymph node biopsy of breast cancer.Gland Surg. 2022 Sep;11(9):1489-1496. doi: 10.21037/gs-22-434. Gland Surg. 2022. PMID: 36221275 Free PMC article.
-
Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study.BMC Surg. 2023 May 17;23(1):133. doi: 10.1186/s12893-023-02037-z. BMC Surg. 2023. PMID: 37198675 Free PMC article.
-
Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2020 May 1;21(5):1187-1195. doi: 10.31557/APJCP.2020.21.5.1187. Asian Pac J Cancer Prev. 2020. PMID: 32458621 Free PMC article.
-
The use of indocyanine green and near-infrared fluorescence imaging to assist sentinel lymph node biopsy in cutaneous melanoma: A systematic review.Eur J Surg Oncol. 2021 May;47(5):935-941. doi: 10.1016/j.ejso.2020.10.027. Epub 2020 Oct 24. Eur J Surg Oncol. 2021. PMID: 33121851
Cited by
-
Indocyanine Green Fluorescence Imaging in the Surgical Management of Skin Squamous Cell Carcinoma.Clin Cosmet Investig Dermatol. 2023 Nov 15;16:3309-3320. doi: 10.2147/CCID.S413266. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 38021421 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous